Top section
Top section
Qualifying shareholders take up 68% as remainder stays with conditional placees
Private equity company cashes in on remaining holding after earlier divestments
More articles
More articles
More articles
-
Global equity markets' red October caught many by surprise. It was an unusual coincidence of mostly positive earnings reports and the worst month of stock performance for some time. Anyone looking to bring a deal to the market should pay more attention to the direction of travel than scavenging for positives with which to paint a rosy picture. -
MUFG has named Zahra Sadry as head of EMEA healthcare coverage, moving her over from the group’s strategic finance team, where she was the MD responsible for Germany, Austria and Switzerland.
-
Primepulse, the German investment fund focused on the technology sector, has postponed its IPO on the Frankfurt Stock Exchange as a result of poor market conditions.
-
BioPharma Credit, the UK closed-end investment fund that provides debt funding to the life sciences industry, has priced its latest capital raise, growing the deal to $305m.
-
Wire and cable manufacturer Polycab India is planning an IPO of new and existing stock, as backer International Finance Corp looks to cash in part of its stake.
-
A stunning rally in Innovent Biologics caught the market’s attention this week, after the shares surged as much as 46% following their debut in Hong Kong on Wednesday. But whether it marks a turning point for the city’s biotechnology listings — which have performed dismally in the secondary market so far — is less clear, writes John Loh.
Sub-sections
shared comment list
